🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522523-96-00
Authorised Phase I

A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma

2025-522523-96-00 · tracked via the Priya Life Science EU tracker
Sponsor
Kyowa Kirin Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
01/04/2026
Enrollment target
34
Sites
Spain, Italy

Condition studied

T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522523-96-00 on CTIS ↗ ← All trials in the EU